UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estetrol improves quality of life in advanced castration-sensitive prostate cancer: A randomized clinical trial

European urology open science (Online), 2022-08, Vol.42, p.S29

2022

Volltextzugriff (PDF)

Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer

European urology open science (Online), 2022-08, Vol.42, p.S3

2022

Volltextzugriff (PDF)

Endocrine approaches in the therapy of prostate carcinoma

Human reproduction update, 2005-05, Vol.11 (3), p.309-317

2005

Volltextzugriff (PDF)

Precision Surgery and Genitourinary Cancers

European journal of surgical oncology, 2017-05, Vol.43 (5), p.893-908

2017

Volltextzugriff (PDF)

Current status of thermotherapy of the prostate

The Journal of urology, 1997-02, Vol.157 (2), p.430-438

1997

Volltextzugriff (PDF)

Transrectal and transperineal MRI-guided prostate cancer pathways in biopsy-naïve men

European urology, 2021-06, Vol.79, p.S1327-S1328

2021

Volltextzugriff (PDF)

Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer

Urology (Ridgewood, N.J.), 1998-09, Vol.52 (3), p.403-410

1998

Volltextzugriff (PDF)

Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score

Urology (Ridgewood, N.J.), 1996-09, Vol.48 (3), p.393-397

1996

Volltextzugriff (PDF)

Intratumoral nuclear morphologic heterogeneity in prostate cancer

Urology (Ridgewood, N.J.), 1997-04, Vol.49 (4), p.652-657

1997

Volltextzugriff (PDF)

招聘講演1 Renal Cell Carcinoma; New Clinical and Investigative Approaches

日本腎臓学会誌, 1994, Vol.36(sup), pp.1-2

1994

Volltextzugriff (PDF)

Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia

European urology, 2003-12, Vol.44 (6), p.695-700

2003

Volltextzugriff (PDF)

Changes in keratin expression during the development of benign prostatic hyperplasia

European urology, 1997-01, Vol.32 (3), p.332-338

1997

Volltextzugriff (PDF)

Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic Hyperplasia

European urology, 1998, Vol.34 (3), p.169-175

1998

Volltextzugriff (PDF)

239 Testosterone treatment is not associated with increased risk of prostate cancer or cardiovascular events: Results from the Registry of Hypogonadism in Men (RHYME)

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e239-e239a

2015

Volltextzugriff (PDF)

Factors affecting recurrence and progression in superficial bladder tumours

European journal of cancer (1990), 1995-10, Vol.31 (11), p.1840-1846

1995

Volltextzugriff (PDF)

Prognostic Factors in Superficial Bladder Cancer

European urology, 1992, Vol.21 (2), p.89-97

1992

Volltextzugriff (PDF)

Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia

The Journal of urology, 2006-01, Vol.175 (1), p.213-216

2006

Volltextzugriff (PDF)

Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma

Urology (Ridgewood, N.J.), 1999-08, Vol.54 (2), p.273-277

1999

Volltextzugriff (PDF)

Transurethral resection vs microwave thermotherapy of the prostate: a cost‐consequences analysis

BJU international, 2003-11, Vol.92 (7), p.713-718

2003

Volltextzugriff (PDF)

PD-02.11

Urology (Ridgewood, N.J.), 2006-11, Vol.68, p.8-9

2006

Volltextzugriff (PDF)

Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer

The Journal of urology, 1998-11, Vol.160 (5), p.1668-1672

1998

Volltextzugriff (PDF)

Improved Subjective Responses to Orchiectomy plus Nilutamide (Anandron) in Comparison to Orchiectomy plus Placebo in Metastatic Prostate Cancer

European urology, 1995-01, Vol.27 (3), p.196-201

1995

Volltextzugriff (PDF)

Improved reliability of uroflowmetry investigations: results of a portable home‐based uroflowmetry study

British Journal of Urology, 1996-09, Vol.78 (3), p.385-390

1996

Volltextzugriff (PDF)

The effects of successive high-energy shock-wave tumor administration on tumor blood flow

Ultrasound in medicine & biology, 1995, Vol.21 (2), p.243-248

1995

Volltextzugriff (PDF)

Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with Alpha1-blockers and watchful waiting

Urology (Ridgewood, N.J.), 2005-02, Vol.65 (2), p.300-305

2005

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(222)
Tagungsberichte
(16)

Sprache

Englisch
(237)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Estetrol improves quality of life in advanced castration-sensitive prostate cancer: A randomized clinical trial

Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer

Endocrine approaches in the therapy of prostate carcinoma

Precision Surgery and Genitourinary Cancers

Current status of thermotherapy of the prostate

Transrectal and transperineal MRI-guided prostate cancer pathways in biopsy-naïve men

Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer

Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score

Intratumoral nuclear morphologic heterogeneity in prostate cancer

招聘講演1 Renal Cell Carcinoma; New Clinical and Investigative Approaches

Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia

Changes in keratin expression during the development of benign prostatic hyperplasia

Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic Hyperplasia

239 Testosterone treatment is not associated with increased risk of prostate cancer or cardiovascular events: Results from the Registry of Hypogonadism in Men (RHYME)

Factors affecting recurrence and progression in superficial bladder tumours

Prognostic Factors in Superficial Bladder Cancer

Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia

Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma

Transurethral resection vs microwave thermotherapy of the prostate: a cost‐consequences analysis

PD-02.11

Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer

Improved Subjective Responses to Orchiectomy plus Nilutamide (Anandron) in Comparison to Orchiectomy plus Placebo in Metastatic Prostate Cancer

Improved reliability of uroflowmetry investigations: results of a portable home‐based uroflowmetry study

The effects of successive high-energy shock-wave tumor administration on tumor blood flow

Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with Alpha1-blockers and watchful waiting

Suchergebnisse filtern